European Commission orders France to lift ban on acne pillBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f4932 (Published 05 August 2013) Cite this as: BMJ 2013;347:f4932
- Sophie Arie
France has been forced to allow sales of Bayer’s acne pill Diane-35 despite its concerns over possible fatal side effects, after the European Commission ruled that the drug was safe.
Sales of Diane-35 (known as Dianette in the United Kingdom) were banned in France in May amid concerns that the drug, which contains cyproterone and ethinyestradiol, could cause thrombosis and pulmonary embolism. The drug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial